AZ Said Leaning To Buy Out Indian Unit To Beat Pending Law
This article was originally published in PharmAsia News
AstraZeneca is considering a purchase of the 10% stake in its AstraZeneca Pharma India unit it does not already own and then remove it from India’s stock exchange.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.